Put down your laptop and step away from the Cyber Monday deals: Beyonce has just released a new holiday line, and we're crazy in love with it.
Holiday-themed merch is usually an utter bore, but leave it to Queen Bey to make it fabulous. She has officially taken the 'ugly' out of 'ugly Christmas sweater'.
Beyonce quietly launched her new holiday clothing line just ahead of Black Friday and it will have you slaying all season long. Her new apparel has sayings like “Have a Thicc Holiday,” “Holidayoncé”, “Sis the Season,” and “Slay Bells.”
She also has a set of ornaments (Bee Yoncé, which features a bee with a Santa hat), a not-even-a-little-ugly Beyoncé Holiday Sweater, and a “Best Revenge is Your Wrapping Paper” that are sure to make quite the statement. Then again, when has the highest-paid woman in the music industry ever had trouble pleasing us?
And the best part? It's affordable.
The collection begins at $12 - yup, $12 - for Christmas tree ornaments and goes as high as $85 for Yoncé adult onesies. Even more surprising, no item is over $100.
Beyoncé has given us the gift that keeps on giving - affordable merchandise. Better get those credit cards into formation, ladies. Her merch can be found here.
Get latest and greatest stories every day in your email inbox.
The company just published a report of its Stage 2 trials for the vaccine, which it says had "positive results" for trialists of all ages, and it has started a Stage 3 trial with more than 30,000 subjects in North America, South America and Europe.
"We expect to have enrolled all participants in our Phase 3 clinical trials by end of spring and be able to analyze and publish the data early summer, at which point we would submit for regulatory approval from Health Canada," a spokesperson from Medicago, which is based out of Quebec City, told Narcity over email.
Medicago reported no related severe adverse effects during Stage 2 of its vaccine trial, and the company said that people who received two doses of its vaccine had "neutralizing antibody responses" that were 10 times higher than people recovering from COVID-19.